An Analysis of NICE ‘Restricted’ (or ‘Optimized’) Decisions

Article examins the attempt to develop a robust and defensible means of measuring and describing the degree of patient access in mixed NICE decisions.(Source: Pharmacoeconomics, O’Neill et al)

You might also be interested in:

KAM Metrics: Driving Efficiency, Measuring Success April 5, 2018
Top 5 Signs You Are Ready for an Online Master’s Degree in… June 12, 2018
Article: Method for Measuring, Tracking Low-Value Care Could Cut Waste May 1, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
Online MS in Applied PharmacoEconomics or Managed Care from… March 1, 2018
Panelists Discuss Challenges of Measuring Value in High-Cost… May 27, 2018
CMS' Final Inpatient Payment Rule Draws Mixed Reactions August 6, 2018